EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR)

[1]  S. Brouillet,et al.  Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors , 2012, Cellular and Molecular Life Sciences.

[2]  S. Brennecke,et al.  Homeobox gene Distal-Less 3 is a regulator of villous cytotrophoblast differentiation and its expression is increased in human idiopathic foetal growth restriction , 2012, Journal of Molecular Medicine.

[3]  J. Kingdom,et al.  Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A. , 2011, Placenta.

[4]  S. Brennecke,et al.  Homeobox Gene HLX Is a Regulator of HGF/c-met-Mediated Migration of Human Trophoblast-Derived Cell Lines1 , 2010, Biology of reproduction.

[5]  S. Brouillet,et al.  Molecular Characterization of EG-VEGF-mediated Angiogenesis: Differential Effects on Microvascular and Macrovascular Endothelial Cells , 2010, Molecular biology of the cell.

[6]  C. Mazouni,et al.  Role of EG‐VEGF in human placentation: Physiological and pathological implications , 2009, Journal of cellular and molecular medicine.

[7]  R. Gish,et al.  Editorial: To “Be” or Not to “Be”: That Is the Question , 2009, The American Journal of Gastroenterology.

[8]  V. Winn,et al.  Vasculogenesis and angiogenesis in the IUGR placenta. , 2008, Seminars in perinatology.

[9]  S. Brennecke,et al.  Homeobox gene HLX1 is a regulator of colony stimulating factor-1 dependent trophoblast cell proliferation. , 2007, Placenta.

[10]  N. Alfaidy,et al.  Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. , 2007, Placenta.

[11]  S. Brennecke,et al.  Homeobox genes are differentially expressed in macrovascular human umbilical vein endothelial cells and microvascular placental endothelial cells. , 2007, Placenta.

[12]  J. Vuoristo,et al.  Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction , 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[13]  S. Brennecke,et al.  Homeobox gene DLX4 expression is increased in idiopathic human fetal growth restriction. , 2006, Molecular human reproduction.

[14]  N. Alfaidy,et al.  Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. , 2006, Endocrinology.

[15]  S. Brennecke,et al.  Homeobox gene HLX1 expression is decreased in idiopathic human fetal growth restriction. , 2006, The American journal of pathology.

[16]  Thomas Jansson,et al.  Placental Phenotypes of Intrauterine Growth , 2005, Pediatric Research.

[17]  Sandy Wilson,et al.  Identification and Pharmacological Characterization of Prokineticin 2β as a Selective Ligand for Prokineticin Receptor 1 , 2005, Molecular Pharmacology.

[18]  Y. Sadovsky,et al.  Microarray-based identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses. , 2005, Placenta.

[19]  Dr Ahmet Alexander Baschat,et al.  Fetal responses to placental insufficiency: an update , 2004, BJOG : an international journal of obstetrics and gynaecology.

[20]  E. Thom,et al.  Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. , 2004, American journal of obstetrics and gynecology.

[21]  D. Torry,et al.  Determinants of Placental Vascularity , 2004, American journal of reproductive immunology.

[22]  Qun Zhou,et al.  Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. , 2004, Molecular pharmacology.

[23]  P. Plsek,et al.  The Vermont Oxford Network: Improving Quality and Safety Through Multidisciplinary Collaboration , 2004 .

[24]  T. Heidmann,et al.  Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Meidan,et al.  Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. , 2003, The Journal of clinical endocrinology and metabolism.

[26]  M. Vidaud,et al.  Direct Involvement of HERV-W Env Glycoprotein in Human Trophoblast Cell Fusion and Differentiation , 2003, Molecular and Cellular Biology.

[27]  J. Kingdom,et al.  Genes, development and evolution of the placenta. , 2003, Placenta.

[28]  P. Baker,et al.  Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. , 2003, Placenta.

[29]  Chie-Pein Chen,et al.  Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. , 2002, American journal of obstetrics and gynecology.

[30]  Qun Zhou,et al.  Identification and Molecular Characterization of Two Closely Related G Protein-coupled Receptors Activated by Prokineticins/Endocrine Gland Vascular Endothelial Growth Factor* , 2002, The Journal of Biological Chemistry.

[31]  P Kaufmann,et al.  Mechanisms of syncytial fusion: a review. , 2002, Placenta.

[32]  T. Regnault,et al.  Placental development in normal and compromised pregnancies-- a review. , 2002, Placenta.

[33]  F. Peale,et al.  Identification of an angiogenic mitogen selective for endocrine gland endothelium , 2001, Nature.

[34]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[35]  D. Luton,et al.  Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. , 2000, The Journal of clinical endocrinology and metabolism.

[36]  B Huppertz,et al.  Development of the placental villous tree and its consequences for fetal growth. , 2000, European journal of obstetrics, gynecology, and reproductive biology.

[37]  M. McMahon,et al.  Placental Apoptosis in Preeclampsia , 2000, Obstetrics and gynecology.

[38]  E. Jauniaux,et al.  Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. , 1999, American journal of obstetrics and gynecology.

[39]  Judith E. Cartwright,et al.  Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide , 1999, British journal of pharmacology.

[40]  S. Fisher,et al.  Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. , 1999, The American journal of pathology.

[41]  M. Post,et al.  Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. , 1999, The Journal of clinical investigation.

[42]  T. Henriksen.  Foetal nutrition, foetal growth restriction and health later in life , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[43]  D. Morrish,et al.  Functional regulation of human trophoblast differentiation. , 1998, Journal of reproductive immunology.

[44]  P. Baker,et al.  Increased placental apoptosis in intrauterine growth restriction. , 1997, American journal of obstetrics and gynecology.

[45]  S. Fisher,et al.  Regulation of human placental development by oxygen tension. , 1997, Science.

[46]  C. Damsky,et al.  Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? , 1997, The Journal of clinical investigation.

[47]  J. Kingdom,et al.  Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. , 1996, American journal of obstetrics and gynecology.

[48]  J. Irving,et al.  Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. , 1995, Experimental cell research.

[49]  S. Nozawa,et al.  Experimental growth retardation produced by transient period of uteroplacental ischemia in pregnant Sprague-Dawley rats. , 1994, American journal of obstetrics and gynecology.

[50]  V. Han,et al.  Localization of transforming growth factor alpha in the human placenta and decidua: role in trophoblast growth. , 1993, Biology of reproduction.

[51]  R. K. Miller,et al.  In vitro differentiation and ultrastructure of human extravillous trophoblast (EVT) cells. , 1993, Placenta.

[52]  T. Unterman,et al.  Maternal Hypoxia as a Model for Intrauterine Growth Retardation: Effects on Insulin-Like Growth Factors and Their Binding Proteins , 1993, Pediatric Research.

[53]  J. Lin,et al.  Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. , 1993, Endocrinology.

[54]  M. Divon,et al.  Intrauterine Growth Retardation: Definition, Classification, and Etiology , 1992, Clinical obstetrics and gynecology.

[55]  G. Douglas,et al.  Differentiation of human trophoblast cells in vitro as revealed by immunocytochemical staining of desmoplakin and nuclei. , 1990, Journal of cell science.

[56]  F. de Wolf,et al.  Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. , 1987, British journal of obstetrics and gynaecology.

[57]  H. Kliman,et al.  Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. , 1986, Endocrinology.

[58]  C. McCarthy,et al.  Altered gene expression patterns in intrauterine growth restriction: potential role of hypoxia. , 2007, American journal of obstetrics and gynecology.

[59]  H. Matsuo,et al.  Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. , 2002, American journal of obstetrics and gynecology.

[60]  D. Nelson,et al.  CURRENT TOPIC: To Be, or Not to Be, That is the Question. Apoptosis in Human Trophoblast , 2000 .

[61]  G. Badger,et al.  Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. , 2000, American journal of obstetrics and gynecology.

[62]  G. Badger,et al.  Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction , 2000 .

[63]  J. Kingdom,et al.  Oxygen and placental vascular development. , 1999, Advances in experimental medicine and biology.

[64]  D. Leon,et al.  Fetal growth and adult disease. , 1998, European journal of clinical nutrition.